Karius logo — Detecting Microbes that Impact Human Health

Karius

Detecting Microbes that Impact Human Health

Founded 2014 United States Redwood City, United States 212 employees Series C Total: $345.00M Biotechnology

General Information

Company Name Karius
Founded Year 2014
Location United States Redwood City, United States
Employees 212
Industries Biotechnology
Funding Stage Series C
Business Model B2B2C, B2B
Revenue Model Service Fee, Usage Based, Tiered Pricing
Social

BounceWatch is an independent company data service, not affiliated with Karius. To contact Karius, visit kariusdx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Karius compare?

A PDF of Karius and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Karius soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Event Participation Oct 06, 2026

Karius will be participating as an exhibitor at IDWeek2026 from October 21-24.

About Karius

Karius, founded in 2014, is a biotechnology company pioneering advancements in clinical metagenomics with its compelling slogan, "Detecting Microbes that Impact Human Health." The company is dedicated to transforming patient care by providing timely and precise microbial insights, thereby minimizing the threat of infectious diseases.

Recently, Karius secured a significant $100.00M in Series C funding as of 01 May 2024. This investment was led by a diverse array of investors, including HBM Healthcare Investments, Khosla Ventures, Seventure Partners, 5AM Ventures, General Catalyst, Gilde Healthcare, Innovation Endeavors, SoftBank Vision Fund, Blue Water Life Science Advisors, and Waycross Ventures.

The company's innovative focus on clinical metagenomics aligns well with ongoing trends in biotechnology and personalized medicine, positioning Karius as a promising leader in the diagnostic space. Its strategic backing and forward-thinking approach make it a noteworthy contender in addressing global healthcare challenges.

Business keywords: Clinical Metagenomics, Microbial Insights, Diagnostics, Genomics, Liquid Biopsy, Cell-free DNA, Bioinformatics, Computational Biology, Infectious Diseases, Global Health, Clinical Care, Immunocompromised, Microbiology

Services & Products

Karius Spectrum blood test
Karius Focus | BAL fluid test
pathogen detection and classification
clinical metagenomic solutions

Target Customers

clinical laboratories healthcare providers immunocompromised patients biotech and life sciences companies

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Series C $100.00M 10
HBM Healthcare Investments, Khosla Ventures +8
01 May 2024
Series B Undisclosed 2
HBM Healthcare Investments, HBM Partners
01 Mar 2022
Series B Undisclosed 1
HBM Healthcare Investments
01 Jan 2021
Series B $165.00M 4
Khosla Ventures, General Catalyst +2
01 Feb 2020
Debt Financing $25.00M 1
Oxford Finance
01 Nov 2018
Series A $50.00M 7
Lightspeed Venture Partners, DCVC +5
01 Aug 2017
Seed $5.00M 3
Lightspeed Venture Partners, DCVC +1
01 Sep 2014

Karius Alternatives & Competitors

View All Alternatives
Karius vs
CareDx, Inc.
CareDx, Inc. United States

Creating life-changing solutions that enable transplant patients to thrive.

Post-IPO Equity
812 employees
Biotechnology, Health Care
Karius vs

Founded in November, 2014, Genecast (Beijing) Biotechnology Co. is located in HealthWork (Beijing) I...

Series E
21 employees
Biotechnology, Health Care
Karius vs
Ophiomics
Ophiomics Portugal

Precision Medicine solutions

Grant
11 employees
Biotechnology, Health Care

FAQ About Karius

Detecting Microbes that Impact Human Health
Karius was founded in 2014.
Karius is headquartered in Redwood City, United States.
Karius operates in Biotechnology. Its work centres on Clinical Metagenomics, Microbial Insights, Diagnostics and Genomics. Its customers include clinical laboratories, healthcare providers and immunocompromised patients.
Karius has a B2B2C and B2B business model. Its revenue comes from Service Fee, Usage Based and Tiered Pricing.
Karius has approximately 212 employees.
Karius has completed 7 funding rounds, raising a total of $345.00M. The latest funding stage is Series C.
Karius offers: Karius Spectrum blood test, Karius Focus | BAL fluid test, pathogen detection and classification, clinical metagenomic solutions.
Top alternatives and competitors to Karius include CareDx, Inc., GeneCast Biotechnology Co., Ltd., Ophiomics, Centrillion Technology, Inc., Fabric Genomics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Karius and CareDx, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Karius, https://bouncewatch.com/company/karius, updated 3 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes